, further purified using triethylaminoethyl-cellulose column chromatography, and identified by the method of Gonzalez-Sastre and Folch-Pi (9), using thin-layer chromatography and visualization by iodine, which yielded a single spot with an RF value the same as the reported one. The P3-inositide spot was removed and the phosphate content was determined by Bartlett's method (10). On the basis of the phosphate determination, the P3inositide was over 95% pure. P3[3H]inositide (specific activity 3 Ci/mmol) was prepared by
ABSTRACT The concentrations of nicotinic drugs required to effect a 50% transfer of triphospho [3H] inositide from an aqueous phase to a nonaqueous phase closely approximated their concentrations for both in vivo neuromuscular blocking activity and binding to purified nicotinic receptors, and correlated well (correlation coefficient = 0.95) with their biological activities measured by other workers in an Electrophorus electroplax preparation. The triphospho[3Hjinositide transfer induced by nicotinic ligands was dependent on the lipid concentration and was potentiated by Ca +. The affinity constants of 45Ca2+ for triphosphoinositide were similar to those for the purified nicotinic receptor. These and other findings suggest the possibility that triphosphoinositide (phosphatidylinositol bisphosphate) is a binding site of the nicotinic receptor.
Recently, Cavallito (1) and others (2, 3) (6) .
The present study describes selective alterations in the physicochemical properties of P3inositide on interaction with various nicotinic ligands. The alterations have been shown to be related to the neuromuscular blocking activity of these ligands. The results suggest that P3inositide may function as a binding component of the nicotinic cholinergic receptor.
MATERIALS AND METHODS Chemicals. P3inositide was isolated by the method of Michell et al. (8) , further purified using triethylaminoethyl-cellulose column chromatography, and identified by the method of Gonzalez-Sastre and Folch-Pi (9), using thin-layer chromatography and visualization by iodine, which yielded a single spot with an RF value the same as the reported one. The P3-inositide spot was removed and the phosphate content was determined by Bartlett's method (10 Tris buffer containing drug and/or cation at room temperature. This aqueous solution was mixed with 1 ml of heptane on a Vortex mixer (speed setting at 5) for 1 min and the mixture was centrifuged at 1500 X g for 10 min. A 0.5-ml aliquot of the aqueous phase mixed with 5 ml of Scintiverse cocktail solution (Fisher Scientific Co.) was assayed in a Beckman liquid scintillation counter to determine P3[3H]inositide activity. The radioactivity in the nonaqueous phase (heptane plus interphase) was determined by subtracting the radioactivity in the aqueous phase from the total amount added. The percent of drug-induced P3[3H]inositide transferred from the aqueous phase to the nonaqueous phase was calculated by using the following equation:
radioactivity without -radioactivity with drug drug in aqueous phase in aqueous phase x 100 radioactivity without drug in aqueous phase 45Ca2+ Binding to P3inositide. One hundred milliliters of 45Ca2+ (2 puM) was mixed with 100 ml of the prepared nonradioactive P3inositide micelles (20 jg/ml). An aliquot of the mixture (0.5 ml) was added to a 0.5-ml solution containing various concentrations of unlabeled calcium or neuromuscular blocking agents and the aqueous solution was mixed with 1 ml of heptane on a Vortex mixer (speed at 5) for 1 min. The mixture was centrifuged at 1500 X g for 10 min and the radioactivity of 45Ca2+ in the lower phase was determined by the same method described for the P3[3H]inositide transfer studies.
RESULTS

Distribution of P3[3H]inositide. The radioactive P3inositide
in both the heptane and aqueous phases was determined in the presence and absence of decamethonium, and the amount of labeled P3inositide at the interphase was obtained by subtracting the measured radioactivities from the total added. As shown in Fig. 1 as hexamethonium and mecamylamine were relatively weak. However, it should be noted that mecamylamine, with an IC50 twice that of decamethonium, was only half as potent as decamethonium in the phrenic nerve diaphragm preparation (12) . The IC50 values of the nicotinic ligands were plotted against the biological potencies obtained from the isolated Electrophorus electroplax (Fig. 7) . According to the method of linear regression analysis, the data were fitted to the line (correlation coefficient = 0.95). Table 1 and the values of Kapp (apparent dissociation constant) were obtained from the isolated monocellular electroplaque by Cohen and Changeux (11) .
ligands correlate closely with their in vivo neuromuscular blocking activities.
The precise nature of the interaction between cholinergic ligands and P3inositide in micellar form is not clear, but complex formation appears to alter the physicochemical properties of the lipid molecule to result in increased hydrophobicity (here defined as tendency to leave the aqueous phase). The IC50 values determined are not solely dependent on the affinity (dissociation constant) of the ligand for P3inositide, but also reflect the apparent change in physicochemical properties of the complex formed. Thus, for any given ligand, the ratio of KD to ICWo is a measure of the relative hydrophobicity of the ligand-P3inositide complex. In the case of the stabilizing blocking agent d-tubocurarine, with a KD of 0.2 ,uM (unpublished data) this ratio is approximately 0.4. However, with succinylcholine, a depolarizing blocking agent (KD 1.6 ,uM), the ratio is much lower (0.013), suggesting that at ligand concentrations close to the dissociation constant the succinylcholine-P3inositide complex is less hydrophobic than the complex of d-tubocurarine with P3inositide. At concentrations of succinylcholine closer to the IC50 value, the icomplex with P3-inositide becomes more hydrophobic. Suchbehavior is consistent with ion-pair theory, which states that the formation of intimate ion pairs is dependent on the concentration of the cation in a given concentration of the anion (13, 14) . The formation of two different types of succinylcholine-P3inositide complex may have relevance to our understanding of the biphasic effects of depolarizing neuromuscular blocking agents and of discrimination between stabilizing and depolarizing actions of the nicotinic blocking agents.
It is well known that calcium ion increases the binding of the cholinergic ligands to their receptors (15, 16 (17) . Such proteolipid receptors appear similar to detergent-extracted cholinergic protein receptors except for their immunological properties (18, 19) . Using On the basis of the present findings, it is tempting to speculate that neuromuscular blocking activity of the antagonist type may be elicited via the formation of hydrophobic ligand-receptor complexes, thereby stabilizing the membrane with blockade of the ionic conductance. Furthermore, our findings indicate that physicochemical properties (i.e., hydrophobicity and hydrophilicity) of the ligand-receptor complex may be important in the discrimination of the neuromuscular blocking agents from the stimulating agents.
